435 related articles for article (PubMed ID: 30307615)
1. Neurocardiac regulation: from cardiac mechanisms to novel therapeutic approaches.
Bardsley EN; Paterson DJ
J Physiol; 2020 Jul; 598(14):2957-2976. PubMed ID: 30307615
[TBL] [Abstract][Full Text] [Related]
2. Sympathetic overactivity, hypertension and cardiovascular disease: state of the art.
Grassi G; Drager LF
Curr Med Res Opin; 2024; 40(sup1):5-13. PubMed ID: 38597067
[TBL] [Abstract][Full Text] [Related]
3. Sympathetic overactivity in hypertension and cardiovascular disease.
Manolis AJ; Poulimenos LE; Kallistratos MS; Gavras I; Gavras H
Curr Vasc Pharmacol; 2014 Jan; 12(1):4-15. PubMed ID: 23905597
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.
Li D; Lu CJ; Hao G; Wright H; Woodward L; Liu K; Vergari E; Surdo NC; Herring N; Zaccolo M; Paterson DJ
Hypertension; 2015 Jul; 66(1):190-8. PubMed ID: 25916722
[TBL] [Abstract][Full Text] [Related]
5. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
Esler M; Kaye D
J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of Neuronal Ca2+ Channel Linked to Heightened Sympathetic Phenotype in Prohypertensive States.
Larsen HE; Bardsley EN; Lefkimmiatis K; Paterson DJ
J Neurosci; 2016 Aug; 36(33):8562-73. PubMed ID: 27535905
[TBL] [Abstract][Full Text] [Related]
7. Sympathetic and baroreflex function in hypertension: implications for current and new drugs.
Grassi G
Curr Pharm Des; 2004; 10(29):3579-89. PubMed ID: 15579055
[TBL] [Abstract][Full Text] [Related]
8. New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.
Kiuchi MG; Nolde JM; Villacorta H; Carnagarin R; Chan JJS; Lugo-Gavidia LM; Ho JK; Matthews VB; Dwivedi G; Schlaich MP
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100908
[TBL] [Abstract][Full Text] [Related]
9. Pre-synaptic sympathetic calcium channels, cyclic nucleotide-coupled phosphodiesterases and cardiac excitability.
Li D; Paterson DJ
Semin Cell Dev Biol; 2019 Oct; 94():20-27. PubMed ID: 30658154
[TBL] [Abstract][Full Text] [Related]
10. Sympathetic activation in chronic renal failure.
Schlaich MP; Socratous F; Hennebry S; Eikelis N; Lambert EA; Straznicky N; Esler MD; Lambert GW
J Am Soc Nephrol; 2009 May; 20(5):933-9. PubMed ID: 18799718
[TBL] [Abstract][Full Text] [Related]
11. Calcium antagonists and sympathetic activity in congestive heart failure.
Grassi G; Bertinieri G; Turri C; Dell'Oro R; Mancia G
J Hypertens Suppl; 1998 Oct; 16(6):S9-14. PubMed ID: 9856378
[TBL] [Abstract][Full Text] [Related]
12. Sympathetic overactivity in hypertension. A moving target.
Julius S; Nesbitt S
Am J Hypertens; 1996 Nov; 9(11):113S-120S. PubMed ID: 8931844
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of the Sympathetic Nervous System in the Development and Progression of Pulmonary Arterial Hypertension.
Liu RX; Luo Q; Qiao H; Yu J; Zhang QL; Wang P; Cao YG; Jiang CL; Qu LH
Curr Neurovasc Res; 2017; 14(2):190-198. PubMed ID: 28088894
[TBL] [Abstract][Full Text] [Related]
14. An unsuspected property of natriuretic peptides: promotion of calcium-dependent catecholamine release via protein kinase G-mediated phosphodiesterase type 3 inhibition.
Chan NY; Seyedi N; Takano K; Levi R
Circulation; 2012 Jan; 125(2):298-307. PubMed ID: 22158783
[TBL] [Abstract][Full Text] [Related]
15. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease.
Esler M; Kaye D
J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S1-7. PubMed ID: 11346214
[TBL] [Abstract][Full Text] [Related]
16. The paraventricular nucleus and heart failure.
Pyner S
Exp Physiol; 2014 Feb; 99(2):332-9. PubMed ID: 24317407
[TBL] [Abstract][Full Text] [Related]
17. [Sympathetic overactivity and the kidney].
Habicht A; Watschinger B
Wien Klin Wochenschr; 2003 Sep; 115(17-18):634-40. PubMed ID: 14603734
[TBL] [Abstract][Full Text] [Related]
18. RNA Sequencing Reveals Novel Transcripts from Sympathetic Stellate Ganglia During Cardiac Sympathetic Hyperactivity.
Bardsley EN; Davis H; Ajijola OA; Buckler KJ; Ardell JL; Shivkumar K; Paterson DJ
Sci Rep; 2018 Jun; 8(1):8633. PubMed ID: 29872217
[TBL] [Abstract][Full Text] [Related]
19. Sympathetic overactivity as a cause of hypertension in chronic renal failure.
Augustyniak RA; Tuncel M; Zhang W; Toto RD; Victor RG
J Hypertens; 2002 Jan; 20(1):3-9. PubMed ID: 11791019
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin peptide synthesis and cyclic nucleotide modulation in sympathetic stellate ganglia.
Bardsley EN; Neely OC; Paterson DJ
J Mol Cell Cardiol; 2020 Jan; 138():234-243. PubMed ID: 31836539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
